- Medicine Name: Tepezza
- Generic Name: Teprotumumab-trbw
- Dosage Form & Strength: Injection: 500 mg lyophilized powder in a single-dose vial
- Manufactured By: Horizon Therapeutics
Tepezza is an insulin-like growth factor-1 receptor inhibitor used for the treatment of Thyroid Eye Disease (TED) also known as Graves’ Orbitopathy.
Recommended Dosage: The recommended dose of Tepezza is an intravenous infusion of 10 mg per kg for the initial dose followed by an intravenous infusion of 20 mg per kg every 3 weeks for 7 additional infusions. Do not administer tepezza injection as an intravenous push or bolus. It should not be infused concomitantly with other agents.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.